Chronic kidney disease a global public health problem: approaches and some initiatives
Keywords:
CKD, Erythropoietin, ESRD, glomerulonephritis, KDIGO
Abstract
In the present study an attempt has been made to analysis of the chronic kidney disease (CKD) which is a global public health problem. Understanding the relationship between CKD and other chronic diseases is important to developing a public health policy to improve outcomes. This report contains, how the food habit could be changed with the change of cultural habituation. However, despite the magnitude of the resources committed to the treatment to show about the kidney function, causes of kidney disease and conceptual framework on different type of renal calculi and its prevention and some giving recommendation. It is now well recognized that the prevalence of CKD is increasing all over the world. The global annual growth of number of ESRD patients is reported at 7%. In view of high disease burden, it became an uneven distribution, expensive treatment and because of fact that organized preventive strategies which are not in place in most countries. So, CKD has assumed the proportions of a significant public health problem.
References
Agodoa, L. Y., Appel, L., Bakris, G. L., Beck, G., Bourgoignie, J. and Briggs, J. P. (2001). African American Study of Kidney Disease and Hypertension Study Group) Effect of Ramipril vs. Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis: A Randomized Controlled Trial. Journal of the American Medical Association. 285: 2719–2728.
Barsoum, R. S. (2003). End-Stage Renal Disease in North Africa. Kidney International. 63 (Suppl. 83): S111– 114.
Foley, R. N. (2006). Infections and cardiovascular disease in patients with chronic kidney disease. Adv. Chronic Kidney Dis. 13: 205–208.
Foxman, B. (2003). Epidemiology of Urinary Tract Infections: Incidence, Morbidity, and Economic Costs. Disease-aMonth. 49:53–70.
Ghosh, C. S. and Basu N. (2014). 'Food & Nutrition' . Pp. 195-197, Grantham, J. J., Ye, M., Davidow, C., Holub, B. and Sharma, M. (1997). Evidence for a potent lipid secretagogue in the cyst fluids of patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 6(4): 1242-1249.
Guay-Woodford, L. M., Green, W. J., Lindsey, J. R. and Beier, D. R. (2000). Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated. Hum. Molec. Genet. 9: 769-778.
Hooton, T. (2000) . 'Urinary Tract Infections in Adults.' In Comprehensive Clinical Nephrology, ed. R. J. Johnson and J. Feehally, London: Mosby. 56: 1–12.
Hussain, M., Lai M., Ali, B., Ahmed, S., Zafar, N., Naqvi, A. and Rizvi, A. (1996). Management of Urinary Calculi Associated with Renal Failure. Journal of the Pakistan Medical Association. 45 (8): 205–208.
Imperatore, G., Knowler, W. C., Pettitt, D. J., Kobes, S., Bennett, P. H. and Hanson R. L. (2000). Segregation Analysis of Diabetic Nephropathy in Pima Indians. Diabetes. 49: 1049–1056.
La Vecchia, C., Levi, F. and Lucchini, F. (1995). Mortality from Benign Prostatic Hyperplasia: Worldwide Trends 1950– 92.
Journal of Epidemiology and Community Health. 49:379. Levey, A.S., Eckardt, K.U. and Tsukamoto, Y. (2005). Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 67: 2089–2100.
Levey, A.S., Andreoli, S.P. and Du-Bose, T. (2007). Chronic kidney disease: common, harmful and treatable – World Kidney Day 2007. Am. J. Kidney. Dis. 49: 175–179.
Luke, R. G. (1999). Hypertensive Nephrosclerosis: Pathogenesis and Prevalence. Essential Hypertension Is an Important Cause of End-Stage Renal Disease. Nephrology Dialysis Transplantation. 14: 2271–2278.
Martinez-Maldonado, M. (1998). Hypertension in End-Stage Renal Disease. Kidney International. 54 (68): 67–72.
Mathers, C. D., Lopez, A. D., and C. J. L. Murray. (2006). "The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001." In Global Burden of Disease and Risk Factors, eds. A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. L. Murray. New York: Oxford University Press.
Morton, A. R., Iliescu, E. A. and Wilson J. W. (2002). Nephrology: 1. Investigation and Treatment of Recurrent Kidney Stones. Canadian Medical Association Journal. 166: 213–218.
National Kidney Foundation. (2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am. J. Kidney Dis. 39(Suppl 1): S1–S266.
Oishi, K., Boyle, P., Barry, M. J., Farah, R. F., Gu L. and Jacobson, S. (1998). "Epidemiology and Natural History of Benign Prostatic Hyperplasia." In Fourth International Consultation on BPH, Proceedings, ed. L. Denis, K. Griffiths, S. Khoury, A. T. K. Cockett, J. McConnell, C. Chatelain, G. Murphy, O. Yoshida (Health Publication Ltd.), Plymouth, U. K.: Plymbridge Distributors Ltd. Pp. 23–59.
Parks, J. and Coe F. L. (1996). The Financial Effects of Kidney Stone Prevention. Kidney International. 50 (5): 1706–1712.
Pasternak, M. S., and Rubin, R. H. (1997). "Urinary Tract Tuberculosis." In Diseases of the Kidney, 6th ed., ed. R. W. Schrier and C. W. Gottschalk. Boston: Little, Brown. Pp. 989–1009.
Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A. and Hunsicker L. G. (1995). Blood Pressure Control, Proteinuria, and the Progression of Renal Disease: The Modification of Diet in Renal Disease Study. Annals of Internal Medicine. 123: 754–62.
Robertson, W. G. (2003). Renal Stones in the Tropics. Seminars in Nephrology. 23: 77–87.
Seaquist, E. R., Goets, F. C., Rich, S., Barbosa, J. (1989). Familial Clustering of Diabetic Kidney Disease: Evidence for Genetic Susceptibility to Diabetic Nephropathy. New England Journal of Medicine. 320: 1161–1165.
Seedat, Y. K. (2003). Glomerular Disease in the Tropics. Seminars in Nephrology. 23: 12–20.
Sever, M. S., Erek, E., Vanholder, R., Akoglu, E., Yavuz, M. and Ergin, H. (2001). Marmara Earthquake Study Group. The Marmara Earthquake: Epidemiological Analysis of the Victims with Nephrological Problems. Kidney International. 60: 1114–1123.
Stengel, B., Tarver-Carr, M. E., Powe, N. R., Eberhardt, M. S. and Brancati, F. L. (2003). Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 14(4): 479- 487.
Barsoum, R. S. (2003). End-Stage Renal Disease in North Africa. Kidney International. 63 (Suppl. 83): S111– 114.
Foley, R. N. (2006). Infections and cardiovascular disease in patients with chronic kidney disease. Adv. Chronic Kidney Dis. 13: 205–208.
Foxman, B. (2003). Epidemiology of Urinary Tract Infections: Incidence, Morbidity, and Economic Costs. Disease-aMonth. 49:53–70.
Ghosh, C. S. and Basu N. (2014). 'Food & Nutrition' . Pp. 195-197, Grantham, J. J., Ye, M., Davidow, C., Holub, B. and Sharma, M. (1997). Evidence for a potent lipid secretagogue in the cyst fluids of patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 6(4): 1242-1249.
Guay-Woodford, L. M., Green, W. J., Lindsey, J. R. and Beier, D. R. (2000). Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated. Hum. Molec. Genet. 9: 769-778.
Hooton, T. (2000) . 'Urinary Tract Infections in Adults.' In Comprehensive Clinical Nephrology, ed. R. J. Johnson and J. Feehally, London: Mosby. 56: 1–12.
Hussain, M., Lai M., Ali, B., Ahmed, S., Zafar, N., Naqvi, A. and Rizvi, A. (1996). Management of Urinary Calculi Associated with Renal Failure. Journal of the Pakistan Medical Association. 45 (8): 205–208.
Imperatore, G., Knowler, W. C., Pettitt, D. J., Kobes, S., Bennett, P. H. and Hanson R. L. (2000). Segregation Analysis of Diabetic Nephropathy in Pima Indians. Diabetes. 49: 1049–1056.
La Vecchia, C., Levi, F. and Lucchini, F. (1995). Mortality from Benign Prostatic Hyperplasia: Worldwide Trends 1950– 92.
Journal of Epidemiology and Community Health. 49:379. Levey, A.S., Eckardt, K.U. and Tsukamoto, Y. (2005). Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 67: 2089–2100.
Levey, A.S., Andreoli, S.P. and Du-Bose, T. (2007). Chronic kidney disease: common, harmful and treatable – World Kidney Day 2007. Am. J. Kidney. Dis. 49: 175–179.
Luke, R. G. (1999). Hypertensive Nephrosclerosis: Pathogenesis and Prevalence. Essential Hypertension Is an Important Cause of End-Stage Renal Disease. Nephrology Dialysis Transplantation. 14: 2271–2278.
Martinez-Maldonado, M. (1998). Hypertension in End-Stage Renal Disease. Kidney International. 54 (68): 67–72.
Mathers, C. D., Lopez, A. D., and C. J. L. Murray. (2006). "The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001." In Global Burden of Disease and Risk Factors, eds. A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. L. Murray. New York: Oxford University Press.
Morton, A. R., Iliescu, E. A. and Wilson J. W. (2002). Nephrology: 1. Investigation and Treatment of Recurrent Kidney Stones. Canadian Medical Association Journal. 166: 213–218.
National Kidney Foundation. (2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am. J. Kidney Dis. 39(Suppl 1): S1–S266.
Oishi, K., Boyle, P., Barry, M. J., Farah, R. F., Gu L. and Jacobson, S. (1998). "Epidemiology and Natural History of Benign Prostatic Hyperplasia." In Fourth International Consultation on BPH, Proceedings, ed. L. Denis, K. Griffiths, S. Khoury, A. T. K. Cockett, J. McConnell, C. Chatelain, G. Murphy, O. Yoshida (Health Publication Ltd.), Plymouth, U. K.: Plymbridge Distributors Ltd. Pp. 23–59.
Parks, J. and Coe F. L. (1996). The Financial Effects of Kidney Stone Prevention. Kidney International. 50 (5): 1706–1712.
Pasternak, M. S., and Rubin, R. H. (1997). "Urinary Tract Tuberculosis." In Diseases of the Kidney, 6th ed., ed. R. W. Schrier and C. W. Gottschalk. Boston: Little, Brown. Pp. 989–1009.
Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A. and Hunsicker L. G. (1995). Blood Pressure Control, Proteinuria, and the Progression of Renal Disease: The Modification of Diet in Renal Disease Study. Annals of Internal Medicine. 123: 754–62.
Robertson, W. G. (2003). Renal Stones in the Tropics. Seminars in Nephrology. 23: 77–87.
Seaquist, E. R., Goets, F. C., Rich, S., Barbosa, J. (1989). Familial Clustering of Diabetic Kidney Disease: Evidence for Genetic Susceptibility to Diabetic Nephropathy. New England Journal of Medicine. 320: 1161–1165.
Seedat, Y. K. (2003). Glomerular Disease in the Tropics. Seminars in Nephrology. 23: 12–20.
Sever, M. S., Erek, E., Vanholder, R., Akoglu, E., Yavuz, M. and Ergin, H. (2001). Marmara Earthquake Study Group. The Marmara Earthquake: Epidemiological Analysis of the Victims with Nephrological Problems. Kidney International. 60: 1114–1123.
Stengel, B., Tarver-Carr, M. E., Powe, N. R., Eberhardt, M. S. and Brancati, F. L. (2003). Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 14(4): 479- 487.
Published
2016-02-28
How to Cite
Sardar, R., & Gayen, J. (2016). Chronic kidney disease a global public health problem: approaches and some initiatives. International Journal of Experimental Research and Review, 3, 41-50. Retrieved from https://qtanalytics.in/journals/index.php/IJERR/article/view/1351
Issue
Section
Articles
